Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Long public hearing lays out health risks, industry concerns as committee considers Kratom Consumer Protection Act
Summary
SB 557 would set a minimum purchase age (21), require testing and labeling, ban synthetic concentrated alkaloids and establish licensing and packaging standards for kratom; clinicians and treatment providers described rising dependence and emergency visits while industry and some consumers pushed for distinction between whole‑leaf kratom and synthetic concentrates.
Senate bill 557, the Kratom Consumer Protection Act, drew extended testimony from clinicians, public‑health advocates, business owners and consumers debating how to regulate a product that many witnesses described as sitting between a dietary supplement and a psychoactive substance.
Sponsor Senator Deborah Uchler framed the proposal as a consumer‑protection and youth‑safety measure that would raise the sales age to 21, require labeling of alkaloid content, cap potency for synthetic/semi‑synthetic derivatives, require child‑resistant packaging for certain formulations, forbid marketing to minors and create enforcement tools and licensing…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
